Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-007108
Filing Date
2022-06-30
Accepted
2022-06-30 16:22:01
Documents
1
Period of Report
2022-06-29

Document Format Files

Seq Description Document Type Size
1 form4-06302022_010649.html 4  
1 form4-06302022_010649.xml 4 6363
  Complete submission text file 0001415889-22-007108.txt   7761
Mailing Address C/O INTRABIOTICS PHARMACEUTICALS INC 1009 OAK HILL ROAD, SUITE 201 LAFAYETTE CA 94549
Business Address
Quart Barry D (Reporting) CIK: 0001384243 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38492 | Film No.: 221058292

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Issuer) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations